This inventor holds 1 USPTO granted patent. Top assignee: Centre for Cellular and Molecular Platforms. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Janhavi Pandurangi: Innovator in Neuroinflammation Management
Introduction
Janhavi Pandurangi is a prominent inventor based in Mysuru, India. She has made significant contributions to the field of neuroinflammation and neurodegeneration. Her innovative work focuses on developing methods and compositions that can effectively manage these critical health issues.
Latest Patents
Janhavi holds 1 patent titled "Methods and compositions for managing neuroinflammation and neurodegeneration." This patent describes a method of inhibiting neuroinflammation in neuron-surrounding cells. It includes treating these cells with at least one tyrosine kinase inhibitor or sirtuin-2 inhibitor, or a combination thereof, to inhibit neuroinflammation. Additionally, the patent outlines a method for managing neuroinflammation or neurodegenerative diseases in subjects in need, which involves administering these inhibitors. The composition also includes at least one tyrosine kinase inhibitor or sirtuin-2 inhibitor, optionally along with a pharmaceutically acceptable excipient.
Career Highlights
Janhavi is currently associated with the Centre for Cellular and Molecular Platforms, where she continues her research and development efforts. Her work is pivotal in advancing the understanding and treatment of neuroinflammatory conditions.
Collaborations
Janhavi collaborates with esteemed colleagues such as Suresh Santhi Natesan and Aravinda K Chavalmane, contributing to a dynamic research environment.
Conclusion
Janhavi Pandurangi's innovative approaches to managing neuroinflammation and neurodegeneration highlight her significant role in the scientific community. Her contributions are essential for advancing treatments in this critical area of health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile